You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ELVN Sale Disclosure
Kunkel Lori Anne · SEC Form 4 · Filed Jun 9, 2026
Sale
Calculated transaction value
$66.01K
Kunkel Lori Anne Director
ELVN
Enliven Therapeutics
ELVN
Transaction date
Jun 5, 2026
Public filing date
Jun 9, 2026
Filing lag
Filed 4 days later
ELVN daily price context
Close on/before transaction
$34.71
Jun 5, 2026
First close after public filing
$37
Jun 10, 2026
30-day return after filing
+41.03%
Through Jul 9, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 1,867 shares @ $35.36
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0001536368-26-000004
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$345.35K
Buys / sales
0 / 3
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 5, 2026 | $266.66K |
| Enliven Therapeutics, Inc. ELVN Current | Sale | Jun 5, 2026 | $66.01K |
| Enliven Therapeutics, Inc. ELVN | Sale | Jun 5, 2026 | $12.68K |